Research map: Efficacy and safety of Omadacycline in community-acquired pneumonia among elderly patients: a real-world evidence study

Back to the article

Papers in this map

  1. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America · Joshua P. Metlay · 2019 · 3712 citations · Cited by this paper
  2. Functional analyses of male-specific early-phosphorylated proteins reveal an intrinsically disordered protein required for microgamete release in Plasmodium berghei · 2026 · Related
  3. Burden of Community-Acquired Pneumonia and Unmet Clinical Needs · João Ferreira‐Coimbra · 2020 · 262 citations · Cited by this paper
  4. Incremental diagnostic value of bloodstream pathogen ddPCR for early identification of blood culture-positive bloodstream infection · 2026 · Related
  5. Omadacycline for Community-Acquired Bacterial Pneumonia · Roman Stets · 2019 · 236 citations · Cited by this paper
  6. Construction and validation of a predictive model for HBsAg loss in chronic hepatitis B patients treated with Peg-IFNα-2b · 2026 · Related
  7. Global and Regional Burden of Hospital Admissions for Pneumonia in Older Adults: A Systematic Review and Meta-Analysis · Ting Shi · 2019 · 128 citations · Cited by this paper
  8. Cooperation of transposable elements to endow global networks of initiators of hybrid assembly pathways of endogenous multiprotein complexes · 2026 · Related
  9. Community-acquired pneumonia in critically ill very old patients: a growing problem · Catia Cillóniz · 2020 · 101 citations · Cited by this paper
  10. Longitudinal dynamics and treatment-associated determinants of interferon-gamma responses in tuberculosis: a 10-year retrospective QuantiFERON-TB Gold study · 2026 · Related
  11. Safety and Tolerability of Antimicrobial Agents in the Older Patient · Luca Soraci · 2023 · 75 citations · Cited by this paper
  12. Diagnostic and differential diagnostic value of plasma extracellular vesicle-associated miRNAs in AIDS patients with tuberculosis and non-tuberculous mycobacterial infection · 2026 · Related
  13. The impact of drug interactions and polypharmacy on antimicrobial therapy in the elderly · Andrea Corsonello · 2014 · 64 citations · Cited by this paper
  14. Lipid metabolism in the resuscitation of dormant mycobacterium tuberculosis: molecular resilience, host hijacking, and clinical opportunities · 2026 · Related
  15. Pharmacokinetics and Pharmacodynamics of Oral and Intravenous Omadacycline · Keith A. Rodvold · 2019 · 58 citations · Cited by this paper
  16. Admission CD4+ T cell BTLA expression and its association with infection risk and respiratory outcomes in sepsis · 2026 · Related
  17. Pharmacokinetics and Safety of Omadacycline in Subjects with Impaired Renal Function · Jolene Kay Berg · 2017 · 48 citations · Cited by this paper
  18. Age‐related risk factors for bacterial aetiology in community‐acquired pneumonia · José Miguel Sahuquillo-Arce · 2016 · 40 citations · Cited by this paper
  19. A retrospective analysis of carbapenem-resistant Acinetobacter baumannii-mediated nosocomial pneumonia and the in vitro therapeutic benefit of cefoperazone/sulbactam · Jingjing Xia · 2014 · 32 citations · Cited by this paper
  20. Comprehensive management of pneumonia in older patients · Alain Putot · 2025 · 27 citations · Cited by this paper
  21. Challenges of infectious diseases in older adults: From immunosenescence and inflammaging through antibiotic resistance to management strategies · Francesca Mancinetti · 2024 · 21 citations · Cited by this paper
  22. Epidemiology of community-acquired pneumonia caused by Streptococcus pneumoniae in older adults: a narrative review · Christelle Elias · 2024 · 20 citations · Cited by this paper
  23. Measurement Error Due to Patient Flow in Estimates of Intensive Care Unit Length of Stay · Michael Oscar Harhay · 2017 · 19 citations · Cited by this paper
  24. Clinical characteristics and risk factors of hospital mortality in elderly patients with community-acquired pneumonia · Shasha Li · 2025 · 17 citations · Cited by this paper
  25. Severe community-acquired pneumonia: current concepts and controversies · Pierre‐François Dequin · 2026 · 14 citations · Cited by this paper
  26. Clinical effectiveness of cefoperazone-sulbactam vs. piperacillin-tazobactam for the treatment of pneumonia in elderly patients · Chun‐Ta Huang · 2021 · 13 citations · Cited by this paper
  27. How Antibiotics Should be Prescribed to Hospitalized Elderly Patients with Community-Acquired Pneumonia · Forest Wayne Arnold · 2016 · 9 citations · Cited by this paper
  28. Omadacycline Pharmacokinetics: Characteristics, Contributing Factors, and Clinical Significance · Huan Sun · 2025 · 4 citations · Cited by this paper
  29. Potential Cost Savings Associated with Targeted Substitution of Current Guideline-Concordant Inpatient Agents with Omadacycline for the Treatment of Adult Hospitalized Patients with Community-Acquired Bacterial Pneumonia at High Risk for Clostridioides difficile Infections: Results of Healthcare-Decision Analytic Model from the United States Hospital Perspective · Thomas P. Lodise · 2021 · 3 citations · Cited by this paper
  30. Understanding antibiotic prescribing in the inpatient setting: a synthesis of evidence on determinants and interventions · Sinan Ma · 2026 · 1 citation · Cited by this paper
  31. Comparison of Efficacy and Safety Profiles Between Omadacycline and Moxifloxacin in Elderly Patients with Community‐Acquired Pneumonia: A Randomized, Controlled Trial · Muming Yu · 2025 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)